Live Breaking News & Updates on Poster Discussion|Page 3

Stay updated with breaking news from Poster discussion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gilead and Kite Oncology to Showcase Advances Across the Pipeline Aiming to Address Unmet Needs in Cancer Care at ASCO 2023

– Data Across 30 Abstracts Reinforce Leadership in Metastatic Breast Cancer and Demonstrate Breadth of Pipeline Across Lung, Hematologic, Genitourinary, Gastrointestinal, Gynecological and. | May 17, 2023 ....

Foster City , United States , Domvanalimab Dom , Pembrolizumab Pembro , Etrumadenant Etruma , Axicabtagene Ciloleucel , Zimberelimab Zim , Frank Neumann , Santa Monica , Brexucabtagene Autoleucel Brexu , Gilead Sciences , Drug Administration , Gilead Sciences Inc , Gilead Company , American Society Of Clinical Oncology , Kite Global Head Of Clinical Development , Exchange Commission , Clinical Oncology , Kite Oncology , Bill Grossman , Senior Vice President , Therapeutic Area Head , Data Reinforce Pan Tumor Efficacy , Therapies Continue , Global Head , Highlights Emerging Lung Cancer Pipeline ,

Elevation Oncology Highlights Clinical Data for SYSA1801 (EO-3021) to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023

/PRNewswire/ Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies. ....

United States , Valerie Malyvanh Jansen , Yakun Wang , Corporate Communications Investor Relations , Elevation Oncology Inc , Group Limited , Drug Administration , American Society Of Clinical Oncology , Prnewswire Elevation Oncology Inc , Exchange Commission , American Society , Clinical Oncology , Elevation Oncology , Chief Medical Officer , Poster Discussion , Molecularly Targeted Agents , Session Date , Discussion Date , Investigational New Drug , Private Securities Litigation Reform Act , Oncology Investor , Corporate Communications ,

Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today. ....

United States , United Kingdom , South Korea , Republic Of Korea , Matthew Deyoung , Samuelj Klempner , Douglase Onsi , Leap Therapeutics Inc , Prnewswire Leap Therapeutics Inc , Drug Administration , American Society Of Clinical Oncology , Harvard Medical School , Clinical Oncology , Annual Meeting , Presentation Details , Harvard Medical , Poster Discussion , Gastrointestinal Cancer , Leap Therapeutics , Seriesx Non Voting Convertible Preferred Stock , Nasdaq Global , Annual Report ,

AISA Pharma Announces Upcoming Profervia® Data Presentations at AAN and EULAR

/PRNewswire/ Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,. ....

United States , Andrew Sternlicht , Aisa Pharma Inc , American Academy Of Neurology , Prnewswire Aisa Pharma Inc , European Alliance Of Associations , Positive Phase , Systemic Sclerosis , American Academy , Scientific Platform Session , Noveln Type Specific Calcium Channel Antagonist , Has Potent Activity , Which May Have Implications , Certain Neuropathic Pain , European Alliance , Novel Daily Oral Calcium Channel Blocker , N Channel Selectivity , Poster Discussion , Aisa Pharma ,

ASCO 2022 | The First Dataset of Olverembatinib (HQP1351) in Patients with GIST Demonstrates Therapeutic Potential with a Clinical Benefit Rate of 83.3%

/PRNewswire/ Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),. ....

United States , Hong Kong , Western Australia , Innovent Biologics , Ascentage Pharma , Baibo Qiu , Yifan Zhai , Prnewswire Ascentage Pharma , Major National , American Society Of Clinical Oncology , Md Anderson Cancer Center , Sun Yat Sen University Cancer Center , American Society Of Hematology , China National Medical Products Administration , National Major New Drug Discovery , Dana Farber Cancer Institute , Poster Discussion , American Society , Clinical Oncology , Chief Medical Officer , Annual Meetings , Drug Designations , Track Designation , Main Board , Stock Exchange , Hong Kong Limited ,